A stepwise approach for the management of poisoning with extracorporeal treatments

Seminars in Dialysis

Volumn 27, Issue 4, 2014, Pages 362-370

  Ghannoum, Marc ^a   Roberts, Darren M ^b   Hoffman, Robert S ^c   Ouellet, Georges ^d   Roy, Louise ^e   Decker, Brian Scott ^f   Bouchard, Josée ^g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DISEASE MANAGEMENT; HUMAN; INTOXICATION; PROCEDURES; RENAL REPLACEMENT THERAPY; THERAPY;

ANIMALS; DISEASE MANAGEMENT; HUMANS; POISONING; RENAL DIALYSIS;

EID: 84904055882     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12228     Document Type: Article

References (107)

1. Abel JJ, Rowntree LG, Turner BB: On the removal of diffusible substances from the circulating blood by dialysis. Trans Assoc Am Physicians 58:51-54, 1913
2. Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS: Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 74:1327-1334, 2008
3. Mowry JB, Spyker DA, Cantilena LR, Jr, Bailey JE, Ford M: 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol (Phila) 51:949-1229, 2013
4. Ghannoum M, Nolin TD, Lavergne V, Hoffman RS: Blood purification in toxicology: nephrology's ugly duckling. Adv Chronic Kidney Dis 18:160-166, 2011
5. Lavergne V, Nolin TD, Hoffman RS, Robert D, Gosselin S, Goldfarb DS, Kielstein JT, Mactier R, MacLaren R, Mowry JB, Bunchman TE, Juurlink D, Megarbane B, Anseeuw K, Winchester JF, Dargan PI, Liu KD, Hoegberg LC, Li Y, Calello D, Burdmann EA, Yates C, Laliberte M, Decker BS, Mello-Da-Silva CA, Lavonas E, Ghannoum M: The EXTRIP (Extracorporeal Treatments In Poisoning) workgroup: guideline methodology. Clin Toxicol 50:403-413, 2012
6. Isbister GK, Balit CR, Whyte IM, Dawson A: Valproate overdose: a comparative cohort study of self poisonings. Br J Clin Pharmacol 55:398-404, 2003
7. Bismuth C, Gaultier M, Conso F: [Medullary aplasia after acute colchicine poisoning. 20 cases]. Nouv Presse Med 6:1625-1629, 1977
8. Ozdemir R, Bayrakci B, Teksam O: Fatal poisoning in children: acute colchicine intoxication and new treatment approaches. Clin Toxicol (Phila) 49:739-743, 2011
9. Proudfoot AT, Stewart MS, Levitt T, Widdop B: Paraquat poisoning: significance of plasma-paraquat concentrations. Lancet 2:330-332, 1979
10. Hart TB, Nevitt A, Whitehead A: A new statistical approach to the prognostic significance of plasma paraquat concentrations. Lancet 2:1222-1223, 1984
11. Rumack BH, Peterson RC, Koch GG, Amara IA: Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 141:380-385, 1981
12. Tenenbein M: Good reasons to publish in Clinical Toxicology. J Toxicol Clin Toxicol 36:137-138, 1998
13. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schunemann HJ, Edejer TT, Varonen H, Vist GE, Williams JW, Jr, Zaza S: Grading quality of evidence and strength of recommendations. BMJ 328:1490, 2004
14. Woo OF, Pond SM, Benowitz NL, Olson KR: Benefit of hemoperfusion in acute theophylline intoxication. J Toxicol Clin Toxicol 22:411-424, 1984
15. Prichard S, Chirito E, Chang T, Sniderman AD: Microencapsulated charcoal hemoperfusion: a possible therapeutic adjunct in digoxin toxicity. J Dial 1:367-377, 1977
16. Hill JB, Palaia FL, McAdams JL, Palmer PJ, Maret SM: Efficacy of activated charcoal hemoperfusion in removing lethal doses of barbiturates and salicylate from the blood of rats and dogs. Clin Chem 22:754-760, 1976
17. Ellsworth H, Engebretsen KM, Hlavenka LM, Kim AK, Cole J, Harris CR, Stellpflug SJ: A cost comparision of fomepizole and hemodialysis in the treatment of methanol and ethylene glycol toxicity. Clin Toxicol 49:515-627, 2011
18. Wiegand TJ, Margaretten M, Olson KR: Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration. Clin Toxicol (Phila) 48:156-159, 2010
19. Sivilotti ML, Juurlink DN, Garland JS, Lenga I, Poley R, Hanly LN, Thompson M: Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila) 51:855-863, 2013
20. Megarbane B, Borron SW, Baud FJ: Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 31:189-195, 2005
21. Tai WP, Yue H, Hu PJ: Coma caused by isoniazid poisoning in a patient treated with pyridoxine and hemodialysis. Adv Ther 25:1085-1088, 2008
22. Myschetzky A, Lassen NA: Urea-induced, osmotic diuresis and alkalization of urine in acute barbiturate intoxication. JAMA 185:936-942, 1963
23. de Silva HA, Fonseka MM, Pathmeswaran A, Alahakone DG, Ratnatilake GA, Gunatilake SB, Ranasinha CD, Lalloo DG, Aronson JK, de Silva HJ: Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet 361:1935-1938, 2003
24. Brahmi N, Kouraichi N, Thabet H, Amamou M: Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Am J Emerg Med 24:440-443, 2006
25. Vale J, Krenzelok EP, Barceloux VD: Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 37:731-751, 1999
26. Proudfoot AT, Krenzelok EP, Vale JA: Position Paper on urine alkalinization. J Toxicol Clin Toxicol 42:1-26, 2004
27. Sikma MA, van den Broek MP, Meulenbelt J: Increased unbound drug fraction in acute carbamazepine intoxication: suitability and effectiveness of high-flux haemodialysis. Intensive Care Med 38:916-917, 2012
28. Muller CH, Lankisch PG: Resin hemoperfusion for carbamazepine intoxication. [German]. Intensivmedizin und Notfallmedizin 26(3):145-148, 1989
29. Roberts DM, Buckley NA: Enhanced elimination in acute barbiturate poisoning-a systematic review. Clin Toxicol (Phila) 49:2-12, 2011
30. Maduell F, Navarro V, Cruz MC, Torregrosa E, Garcia D, Simon V, Ferrero JA: Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis 40:582-589, 2002
31. Matzke GR: Status of hemodialysis of drugs in 2002. J Pharm Pract 15:405-418, 2002
32. Kawasaki C, Nishi R, Uekihara S, Hayano S, Otagiri M: Charcoal hemoperfusion in the treatment of phenytoin overdose. Am J Kidney Dis 35:323-326, 2000
33. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11:2344-2350, 2000
34. Lindholm DD, Murray JS: Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis. N Engl J Med 274:1047-1051, 1966
35. De Bock V, Verbeelen D, Maes V, Sennesael J: Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration. Nephrol Dial Transplant 4:635-639, 1989
36. Decker BS, Kays MB, Chambers M, Kraus MA, Moe SM, Sowinski KM: Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis. Clin J Am Soc Nephrol 5:1981-1987, 2010
37. Klansuwan N, Ratanajamit C, Kasiwong S, Wangsiripaisan A: Clearance of vancomycin during high-efficiency hemodialysis. J Med Assoc Thai 89:986-991, 2006
38. Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA: Pharmacokinetics of vancomycin when administered during high flux hemodialysis. Clin Nephrol 50:51-55, 1998
39. Wolter K, Claus M, Wagner K, Fritschka E: Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis. Clin Nephrol 42:389-397, 1994
40. Vienken J, Christmann H: How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial 10:125-131, 2006
41. Winchester JF, Harbord NB, Rosen H: Management of poisonings: core curriculum 2010. Am J Kidney Dis 56(4):788-800, 2010
42. Martin-Reyes G, Toledo-Rojas R, Torres-de Rueda A, Sola-Moyano E, Blanca-Martos L, Fuentes-Sanchez L, Martinez-Esteban MD, Diez-de los Rios MJ, Bailen-Garcia A, Gonzalez-Molina M, Garcia-Gonzalez I: Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma. Nefrologia 32:35-43, 2012
43. Ahrenholz PG, Winkler RE, Michelsen A, Lang DA, Bowry SK: Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship. Clin Nephrol 62:21-28, 2004
44. Bohler J, Donauer J, Keller F: Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage. Kidney Int Suppl 2:4-28, 1999
45. Bugge JF: Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45:929-934, 2001
46. Kim Z, Goldfarb DS: Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Nephron Clin Pract 115:c1-c6, 2010
47. Forni LG, Hilton PJ: Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 336:1303-1309, 1997
48. Kaiser JP, Oppermann M, Gotze O, Deppisch R, Gohl H, Asmus G, Rohrich B, von Herrath D, Schaefer K: Significant reduction of factor D and immunosuppressive complement fragment Ba by hemofiltration. Blood Purif 13:314-321, 1995
49. Amyot SL, Leblanc M, Thibeault Y, Geadah D, Cardinal J: Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med 25:1169-1172, 1999
50. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis 44:278-285, 2004
51. Ronco C, Breuer B, Bowry SK: Hemodialysis membranes for high-volume hemodialytic therapies: the application of nanotechnology. Hemodial Int 10(Suppl 1):S48-S50, 2006
52. Ward RA: Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application? J Am Soc Nephrol 16:2421-2430, 2005
53. Jeffrey RF, Khan AA, Prabhu P, Todd N, Goutcher E, Will EJ, Davison AM: A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system. Artif Organs 18:425-428, 1994
54. Joy MS, Matzke GR, Frye RF, Palevsky PM: Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Am J Kidney Dis 31:1019-1027, 1998
55. Pond SM: Extracorporeal techniques in the treatment of poisoned patients. Med J Aust 154:617-622, 1991
56. Chang TM: Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int Suppl 7:387-392, 1975
57. Tessore V, Luboz MP, Denti E: Use of uncoated activated carbon hemoperfusion in acute poisoning: in vitro studies. Contrib Nephrol 29:65-75, 1982
58. Rubik J, Pietraszek-Jezierska E, Kaminski A, Skarzynska A, Jozwiak S, Pawlowska J, Drewniak T, Prokurat S, Grenda R, Kalicinski P: Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatr Transplant 8:295-300, 2004
59. Stadlbauer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, Stauber RE: Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 10:R169, 2006
60. Krisper P, Stauber RE: Technology insight: artificial extracorporeal liver support-how does Prometheus compare with MARS? Nat Clin Pract Nephrol 3:267-276, 2007
61. Mitzner S, Klammt S, Stange J, Schmidt R: Albumin regeneration in liver support-comparison of different methods. Ther Apher Dial 10:108-117, 2006
62. Chu G, Mantin R, Shen YM, Baskett G, Sussman H: Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer 72:3707-3714, 1993
63. Pierga JY, Beuzeboc P, Dorval T, Palangie T, Pouillart P: Favourable outcome after plasmapheresis for vincristine overdose. Lancet 340:185, 1992
64. Kuhlmann U, Schoenemann H, Muller T, Keuchel M, Lange H: Plasmapheresis in life-threatening verapamil intoxication. Artif Cells Blood Substit Immobil Biotechnol 28:429-440, 2000
65. Gambi D, Oggioni R, Mangani V, Librenti M, Manescalchi F, Tulli G: [Acute carbamazepine poisoning treated with plasmapheresis. Description of a clinical case]. Minerva Anestesiol 59:547-552, 1993
66. Solomon A, Fahey JL: Plasmapheresis therapy in macroglobulinemia. Ann Intern Med 58:789-800, 1963
67. Fahey JL, Barth WF, Solomon A: Serum hyperviscosity syndrome. JAMA 192:464-467, 1965
68. Jha S, Waghdhare S, Reddi R, Bhattacharya P: Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis. Thyroid 22:1283-1286, 2012
69. Ibrahim RB, Liu C, Cronin SM, Murphy BC, Cha R, Swerdlow P, Edwards DJ: Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy 27:1529-1549, 2007
70. Puisset F, White-Koning M, Kamar N, Huart A, Haberer F, Blasco H, Le Guellec C, Lafont T, Grand A, Rostaing L, Chatelut E, Pourrat J: Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease. Br J Clin Pharmacol 76:734-740, 2013
71. Faed EM: Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics. Eur J Clin Pharmacol 21:77-81, 1981
72. De Pont ACJM: Extracorporeal treatment of intoxications. Curr Opin Crit Care 13:668-673, 2007
73. Higgins RM, Connolly JO, Hendry BM: Alkalinization and hemodialysis in severe salicylate poisoning: comparison of elimination techniques in the same patient. Clin Nephrol 50:178-183, 1998
74. Licari E, Calzavacca P, Warrillow SJ, Bellomo R: Life-threatening sodium valproate overdose: a comparison of two approaches to treatment. Crit Care Med 37:3161-3164, 2009
75. Franssen EJ, van Essen GG, Portman AT, de Jong J, Go G, Stegeman CA, Uges DR: Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Ther Drug Monit 21:289-292, 1999
76. Khan E, Huggan P, Celi L, MacGinley R, Schollum J, Walker R: Sustained low-efficiency dialysis with filtration (SLEDD-f) in the management of acute sodium valproate intoxication. Hemodial Int 12:211-214, 2008
77. van Kuelen JG, van Wijk JA, Touw DJ, van der Deure J, Markhorst DG, Gemke RJ: Effectiveness of haemofiltration in valproic acid intoxication. Acta Paediatr 90:958-959, 2001
78. Goodman JW, Goldfarb DS: The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 19:402-407, 2006
79. Roberts DM, Dawson AH, Senarathna L, Mohamed F, Cheng R, Eaglesham G, Buckley NA: Toxicokinetics, including saturable protein binding, of 4-chloro-2-methyl phenoxyacetic acid (MCPA) in patients with acute poisoning. Toxicol Lett 201:270-276, 2011
80. Roberts DM, Buckley NA: Pharmacokinetic considerations in clinical toxicology: clinical applications. Clin Pharmacokinet 46:897-939, 2007
81. Borkan SC: Extracorporeal therapies for acute intoxications. Crit Care Clin 18(2):393-420, 2002
82. Schuerer DJ, Brophy PD, Maxvold NJ, Kudelka T, Bunchman TE: High-efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol 38:321-323, 2000
83. Tapolyai M, Campbell M, Dailey K, Udvari-Nagy S: Hemodialysis is as effective as hemoperfusion for drug removal in carbamazepine poisoning. Nephron 90:213-215, 2002
84. Ghannoum M, Troyanov S, Ayoub P, Lavergne V, Hewlett T: Successful hemodialysis in a phenytoin overdose: case report and review of the literature. Clin Nephrol 74:59-64, 2010
85. Harder JL, Heung M, Vilay AM, Mueller BA, Segal JH: Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose. Hemodial Int 15:412-415, 2011
86. Kawasaki CI, Nishi R, Uekihara S, Hayano S, Kragh-Hansen U, Otagiri M: How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases? Clin Toxicol (Phila) 43:95-99, 2005
87. Shalkham AS, Kirrane BM, Hoffman RS, Goldfarb DS, Nelson LS: The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis 48:239-241, 2006
88. Sentsov VG, Brusin KM, Meledin VY, Novikova OV, Urazaev TH: Comparison of charcoal hemoperfusion and hemodialysis in treatment of severe carbamazepine intoxications [abstract]. Clin Toxicol (Phila) 45:346, 2007
89. Shannon MW: Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Acad Emerg Med 4:674-678, 1997
90. Ghannoum M, Bouchard J, Nolin T, Ouellet G, Roberts DM: Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance and application in clinical practice. Semin Dial ???:???-???, 2014
91. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F: Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10:R108, 2006
92. Churchwell MD, Pasko DA, Smoyer WE, Mueller BA: Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant 24:231-238, 2009
93. Sen S, Ratnaraj N, Davies NA, Mookerjee RP, Cooper CE, Patsalos PN, Williams R, Jalan R: Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia 44:265-267, 2003
94. Kan G, Jenkins I, Rangan G, Woodroffe A, Rhodes H, Joyce D: Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning. Nephrol Dial Transplant 18:2665-2667, 2003
95. Choi JH, Oh JC, Kim KH, Chong SY, Kang MS, Oh DY: Successful treatment of cisplatin overdose with plasma exchange. Yonsei Med J 43:128-132, 2002
96. Fertel BS, Nelson LS, Goldfarb DS: Extracorporeal removal techniques for the poisoned patient: a review for the intensivist. J Intensive Care Med 25:139-148, 2010
97. Garella S: Extracorporeal techniques in the treatment of exogenous intoxications. Kidney Int 33:735-754, 1988
98. O'Malley G, Zebley T, Wilcox B, Raja R, Firpo J: A massive carbamazepine overdose treated with high-efficiency hemodialysis [abstract]. Clin Toxicol (Phila) 44:684-685, 2006
99. Brodersen HP, Theilmeier A, Korsten S, Arendt U, Larbig D, Reis HE: Acute poisoning by a potentially lethal dose of thallium: quantitative comparison of different methods of elimination. [German]. Intensiv- und Notfallbehandlung 17(4):204-207, 1992
100. Lalau JD, Andrejak M, Moriniere P, Coevoet B, Debussche X, Westeel PF, Fournier A, Quichaud J: Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol 27:285-288, 1989
101. Perrot D, Claris O, Guillaume C, Bouffard Y, Delafosse B, Motin J: Metformin and lactic acidosis: value of initial plasma assay of metformin and hemodialysis. Ann Med Interne (Paris) 137:169-170, 1986
102. Barrueto F, Meggs WJ, Barchman MJ: Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 40:177-180, 2002
103. Ouellette SM, Visconti JA, Kennedy MS: A pharmacokinetic evaluation of the effect of plasma exchange on tobramycin disposition. Clin Exp Dial Apheresis 7:225-233, 1983
104. Alet P, Lortholary O, Fauvelle F, Tod M, Genereau T, Louchahi M, Leon A, Guillevin L, Petitjean O: Pharmacokinetics of teicoplanin during plasma exchange. Clin Microbiol Infect 5:213-218, 1999
105. Ibrahim RB, Balogun RA: Medications in patients treated with therapeutic plasma exchange: prescription dosage, timing, and drug overdose. Semin Dial 25:176-189, 2012
106. Manikian A, Stone S, Hamilton R, Foltin G, Howland MA, Hoffman RS: Exchange transfusion in severe infant salicylism. Vet Hum Toxicol 44:224-227, 2002
107. Osborn HH, Henry G, Wax P, Hoffman R, Howland MA: Theophylline toxicity in a premature neonate-elimination kinetics of exchange transfusion. J Toxicol Clin Toxicol 31:639-644, 1993